A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation
Shoulder Pain
About this trial
This is an interventional diagnostic trial for Shoulder Pain focused on measuring Indirect magnetic resonance arthrogram, Direct magnetic resonance arthrogram, Diagnostic tests for shoulder pain
Eligibility Criteria
Inclusion Criteria:
- Patients between 18 - 70 years old
- Continued shoulder pain for 2 months duration that limits his/her activity despite conservative treatment
- Had a standard of care Direct MR arthrogram performed from which the surgeon determined that arthroscopic surgery was indicated.
Exclusion Criteria:
Clinical Evidence of
- Tumor
- Infection
- Previous shoulder surgery
- Contraindication for MRI
- Allergy to contrast
- Coagulopathy
- Known allergy to gadolinium DTPA
- Renal failure with creatinine clearance of less than 30ml/min
- Pregnancy
Sites / Locations
- Bone and Joint Institute, Penn State Milton S. Hershey Medical Center
Arms of the Study
Arm 1
Experimental
Indirect MRA
After patient has signed consent and had blood tests to ensure normal kidney function (BUN and Creatinine) as well as serum and urine pregnancy tests for females to ensure there is no pregnancy, the patient will have an Indirect MRA. The participant will be weighed and the correct dose of 0.1 mmol/kg calculated. An IV will be inserted into participant's arm. The gadopentetate dimeglumine will be injected into the IV and the patient will be asked to gently exercise the shoulder (small windmills and flexion/extension) for 5 minutes. The patients then undergo MRI imaging 15-30 minutes after the injection. Contraindications include known allergy to gadopentetate dimeglumine, and renal failure with creatinine clearance of less than 30ml/min.